Guangdong's 60 drugs began to cut prices at the end of this month, with an average price reduction of nearly half

【Pharmaceutical Network Industry News】 Since November 30, Guangdong has implemented centralized procurement of 60 more drugs, covering hypertension, diabetes and other drugs, with an average price reduction of 48% and a maximum price reduction of 98%.

It is understood that recently, the website of Guangdong Provincial Medical Security Bureau issued the "Notice of Guangdong Provincial Medical Security Bureau on Doing a Good Job in the Seventh Batch of State-Organized Centralized Procurement and Use of Drugs"
.
According to the "Notice", the scope of the varieties of this collective procurement is the seventh batch of drugs selected by the state joint procurement office cloth to supply Guangdong Province, and the public medical institutions at all levels in the province (including military medical institutions stationed in Guangdong) that have filled in the seventh batch of national procurement requirements, and the private hospitals and retail pharmacies designated by medical insurance that voluntarily participate in the filling in will implement collective procurement
.
The procurement cycle of the seventh batch of national procurement in the first year is from November 30, 2022 to November 29, 2023
.
The "Notice" clarifies that the seventh batch of state-organized centralized procurement of drugs, a total of 60 kinds of drugs were successfully purchased, with an average price reduction of 48%, involving 31 treatment categories, including hypertension, diabetes, anti-infection, digestive tract diseases and other common diseases, chronic diseases, as well as lung
cancer, liver cancer, kidney cancer, bowel cancer and other major diseases.
Taking the domestic hepatitis B drug tenofovir fumarate tenofovir tablets produced by the winning enterprise Qilu Pharmaceutical Co.
, Ltd.
as an example, the winning price was 0.
32 yuan / capsule, a decrease of 98%.

In addition, the average price of lenvatinib capsules, a first-line targeted drug for liver cancer, dropped from 77.
4 yuan to 3.
2 yuan, and a treatment cycle can save 6678 yuan
.
The "hot drug for influenza" antiviral drug oseltamivir capsules dropped from an average of 13.
98 yuan to 1 yuan
per capsule.
The field of centralized procurement of antihypertensive drugs included sustained and controlled release dosage forms, and the price of nifedipine controlled-release tablets was reduced by 85%, and the price of metoprolol sustained-release tablets was reduced by 78%.

According to statistics, after the implementation of this centralized procurement of drugs, the cumulative implementation of national and inter-provincial alliance centralized procurement drugs in Guangdong will reach 341, with an average reduction of more than 50%, effectively reducing the burden of medical expenses on
the people.
It is reported that in order to ensure the stable supply of drugs in collective procurement, the centralized procurement introduced the mechanism of backup supply enterprises to explore the realization of "one province and two supply", that is, each province not only has 1 selected enterprise, that is, the main supply enterprise, but also 1 backup supply enterprise, which is equivalent to "double insurance"
for the stable supply of collective procurement varieties 。 The notice makes it clear that during the implementation process, if the selected enterprise cannot respond to the orders of medical institutions in a timely manner, in order to ensure clinical needs, medical institutions can purchase spare drugs, and the procurement platform should remind the selected enterprises at the same time; When the selected enterprise cannot supply in sufficient quantity in time or is disqualified from the selected enterprise in a large range or for a long time, resulting in the inability to meet the market demand of the selected region or the inability to continue to perform the quantity purchase agreement, the province shall continue to perform the volume purchase agreement
in accordance with the established initiation procedures to prepare the supply enterprise to replace the original selected enterprise.
It is understood that in addition to the centralized procurement of 60 kinds of drugs, since October, Guangdong has also launched the linkage procurement of orthopedic trauma medical consumables, and actively mobilized medical institutions to participate in the centralized procurement of oral implants, reducing the burden of
patients' medical expenses through a multi-pronged approach.
According to statistics, as of the end of June this year, Guangdong has completed the alliance procurement of 12 types of medical consumables and three batches of 541 drugs, especially leading 11 provinces to carry out 494 joint procurement
of drugs.
With a wide range of procurement categories, large volume and wide benefits, the average price of drugs has decreased by 31%, and it is expected to save more than 7 billion yuan
in annual costs.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.